Abvc BioPharma
(NASDAQ) ABVC
Abvc BioPharma Financials at a Glance
Market Cap
$27.73M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.91M
EPS (TTM)
$-0.38
P/E Ratio
-2.84
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$1.09
Volume
725
Open
$1.13
Price
$1.09
Volume
725
Open
$1.13
Previous Close
$1.09
Daily Range
$1.09 - $1.13
52-Week Range
$0.73 - $5.48
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$1.09
Volume
725
Open
$1.13
Previous Close
$1.09
Daily Range
$1.09 - $1.13
52-Week Range
$0.73 - $5.48
ABVC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abvc BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Uttam Yashwant Patil, PhD
Website
www.abvcpharma.comHeadquarters
Fremont, CA 94538, US
ABVC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-128%
Return on Capital
-48%
Return on Assets
-38%
Earnings Yield
-35.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$27.73M
Shares Outstanding
25.44M
Volume
725
Short Interest
0.00%
Avg. Volume
57.40K
Financials (TTM)
Gross Profit
$795.95K
Operating Income
$7.15M
EBITDA
$6.65M
Operating Cash Flow
$2.99M
Capital Expenditure
$5.79K
Free Cash Flow
$2.99M
Cash & ST Invst.
$745.83K
Total Debt
$3.47M
Abvc BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$795.95K
-40585.8%
Gross Profit
$214.04K
-10987.2%
Gross Margin
0.00%
N/A
Market Cap
$27.73M
N/A
Market Cap/Employee
$1.73M
N/A
Employees
16
N/A
Net Income
$3.56M
-1653.8%
EBITDA
$1.98M
-6496.4%
Quarterly Fundamentals
Net Cash
$2.73M
-19.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$1.60M
+576.0%
Short Term Debt
$1.87M
-36.9%
Return on Assets
-37.55%
N/A
Return on Invested Capital
-48.00%
N/A
Free Cash Flow
$1.86M
+476.6%
Operating Cash Flow
$1.86M
+476.6%